Duopharma Biotech Berhad reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was MYR 200.48 million compared to MYR 185.94 million a year ago. Net income was MYR 22.63 million compared to MYR 20.29 million a year ago.

Basic earnings per share from continuing operations was MYR 0.0238 compared to MYR 0.0219 a year ago. Diluted earnings per share from continuing operations was MYR 0.0238 compared to MYR 0.0219 a year ago.